Genesis Molecular Technologies
Biotech company focused on development of a novel molecule derived from approximately 25 years of research in molecular biology and regenerative medicine.
Industries
biopharma
biotechnology
test-and-measurement
Nr. of Employees
small (1-50)
Genesis Molecular Technologies
Austin, Texas, United States, North America
Patents
Substituted imidazo[l,2-a]pyrazines and pyrazino[l,2-a] pyrimidines as topical agents for dermatological applications
US-12168665-B2
View DetailsSubstituted imidazo[1,2-a]pyrazines and pyrazino[1,2-a]pyrimidines as topical agents for dermatological applications
US-11639356-B2
View Details
Substituted imidazo[l,2-a]pyrazines and pyrazino[l,2-a] pyrimidines as topical agents for dermatological applications
US-12168665-B2
View DetailsSubstituted imidazo[1,2-a]pyrazines and pyrazino[1,2-a]pyrimidines as topical agents for dermatological applications
US-11639356-B2
View DetailsProducts
Novel molecule for regenerative medicine
A molecule presented on the company site as the outcome of ~25 years of molecular biology and regenerative medicine research.
Novel molecule for regenerative medicine
A molecule presented on the company site as the outcome of ~25 years of molecular biology and regenerative medicine research.
Expertise Areas
- Molecular biology research
- Regenerative medicine
- Therapeutic molecule development
- Biotechnology research and development
Key Technologies
- Molecular biology techniques
- Regenerative medicine methods
- Therapeutic molecule discovery